Skip to main content
. 2021 Jun 11;12:673532. doi: 10.3389/fimmu.2021.673532

Table 3.

AERAS-402 anti-Ad35 Neutralizing Activity.

Parameter/Study Day (Time) Placebo 2 Doses AERAS-402 (3 x 10^10 vp) 2 Doses
(n=4) (n=8)
Response > LLOQ, n (%)
Study Day 0 (Pre-Vaccination) 3 (75.0) 2 (25.0)
Study Day 182 3 (75.0) 4 (50.0)
Shift from Study Day 0 (Pre-Vaccination) to Study Day 182 (%)
> LLOQ to > LLOQ 3/4 (75.0) 2/8 (25.0)
> LLOQ to <= LLOQ 0/4 (0.0) 0/8 (0.0)
<= LLOQ to <= LLOQ 1/4 (25.0) 4/8 (50.0)
<= LLOQ to > LLOQ 0/4 (0.0) 2/8 (25.0)